Ulf D. Kahlert

3.5k total citations · 1 hit paper
99 papers, 2.4k citations indexed

About

Ulf D. Kahlert is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Ulf D. Kahlert has authored 99 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 35 papers in Cancer Research and 27 papers in Genetics. Recurrent topics in Ulf D. Kahlert's work include Glioma Diagnosis and Treatment (26 papers), MicroRNA in disease regulation (14 papers) and Cancer Cells and Metastasis (13 papers). Ulf D. Kahlert is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), MicroRNA in disease regulation (14 papers) and Cancer Cells and Metastasis (13 papers). Ulf D. Kahlert collaborates with scholars based in Germany, China and United States. Ulf D. Kahlert's co-authors include Jarek Maciaczyk, Guido Nikkhah, Charles G. Eberhart, Frank A.E. Kruyt, Justin V. Joseph, Daniel Hänggi, Abigail K. Suwala, Brent A. Orr, Eric H. Raabe and Hans‐Jakob Steiger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Metabolism and Cancer Research.

In The Last Decade

Ulf D. Kahlert

88 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma

2024 92 citations Guanzhang Li, Di Wang et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Ulf D. Kahlert

Since Specialization

Citations

This map shows the geographic impact of Ulf D. Kahlert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf D. Kahlert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf D. Kahlert more than expected).

Fields of papers citing papers by Ulf D. Kahlert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf D. Kahlert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf D. Kahlert. The network helps show where Ulf D. Kahlert may publish in the future.

Co-authorship network of co-authors of Ulf D. Kahlert

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf D. Kahlert. A scholar is included among the top collaborators of Ulf D. Kahlert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf D. Kahlert. Ulf D. Kahlert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human multiethnic radiogenomics reveals low-abundancy microRNA signature in plasma-derived extracellular vesicles for early diagnosis and molecular subtyping of pancreatic cancer 2025 ·eLife ·(unknown), (unknown), Yi Zhun Zhu, Chao Zhang, (unknown), (unknown), (unknown), Ujjwal Mukund Mahajan, Maciej Pech, G. Scott Rose, Roland S. Croner, (unknown), Christoph Kahlert, Ulf D. Kahlert	0
2	Cloud‐Based GWAS Platform: An Innovative Solution for Efficient Acquisition and Analysis of Genomic Data 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Aimin Jiang, (unknown), Qi Wang, Zhengrui Li, Jian Zhang, (unknown), (unknown), Ulf D. Kahlert, Anqi Lin, (unknown), Peng Luo	0
3	Integrative Disulfidptosis‐Based Risk Assessment for Prognostic Stratification and Immune Profiling in Glioma 2025 ·Journal of Cellular and Molecular Medicine ·(unknown), Guangzhao Li, Ulf D. Kahlert, (unknown), Jing Zheng, (unknown), (unknown), (unknown), Zhengquan Yu	4
4	Artificial intelligence-based radiogenomics reveals the potential immunoregulatory role of COL22A1 in glioma and its induced autoimmune encephalitis 2025 ·Frontiers in Immunology ·(unknown), Qian Chen, Da‐Cheng Wang, (unknown), (unknown), (unknown), (unknown), Ulf D. Kahlert, Zhengquan Yu	4
5	Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma breakdown → 2024 ·Cell Metabolism ·Guanzhang Li, Di Wang, You Zhai, Changqing Pan, (unknown), Chen Wang, Ruoyu Huang, Mingchen Yu, Yiming Li, Xing Liu, Yanwei Liu, Fan Wu, (unknown), Huimin Hu, Zhongfang Shi, Ulf D. Kahlert, Tao Jiang, (unknown)	92
6	Hidden Appendicoliths and Their Impact on the Severity and Treatment of Acute Appendicitis 2024 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Mihailo Andric, Ulf D. Kahlert, Tobias Hofmann, Michael Boettcher, Luis E. Muñoz, Martin Herrmann, Aristotelis Perrakis, Roland S. Croner	1
7	Ultrasound genomics related mitochondrial gene signature for prognosis and neoadjuvant chemotherapy resistance in triple negative breast cancer 2024 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·(unknown), (unknown), Luz Angela Torres-de la Roche, Rudy Leon De Wilde, Guilin Wang, Dong Zeng, (unknown), Ulf D. Kahlert, Wenjie Shi	0
8	Unlocking Clinical Insights: Lymphocyte-Specific Protein Tyrosine Kinase Candidates as Promising Therapeutic Targets for Pancreatic Cancer Risk Stratification 2024 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), (unknown), Thomas Wartmann, (unknown), (unknown), (unknown), Roland S. Croner, (unknown), (unknown), Ulf D. Kahlert	1
9	The tumor–neutrophil interactions in the microenvironment of brain metastases with different primary sites 2024 ·Journal of Leukocyte Biology ·Tijen Kaya, Klaus‐Peter Stein, (unknown), Belal Neyazi, A.M. Rashidi, Ulf D. Kahlert, Christian Mawrin, I. Erol Sandalcioglu, Claudia A. Dumitru	3
10	Inflammatory Signals Across the Spectrum: A Detailed Exploration of Acute Appendicitis Stages According to EAES 2015 Guidelines 2024 ·Diagnostics ·(unknown), Mihailo Andric, (unknown), (unknown), (unknown), (unknown), (unknown), Cora Wex, Ulf D. Kahlert, Martin Herrmann, Aristotelis Perrakis, Roland S. Croner	1
11	Rapid, label-free classification of glioblastoma differentiation status combining confocal Raman spectroscopy and machine learning 2023 ·The Analyst ·(unknown), Björn Fischer, Volker Neuschmelting, (unknown), Igor Fischer, Roland S. Croner, Roland Goldbrunner, Michael C. Hacker, Jakub Dybaś, Ulf D. Kahlert	11
12	Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer 2023 ·British Journal of Cancer ·Wenjie Shi, Thomas Wartmann, (unknown), (unknown), Aristotelis Perrakis, Christoph Kahlert, Alexander Link, Marino Venerito, Verena Keitel, Christiane J. Bruns, Roland S. Croner, Yue Zhao, Ulf D. Kahlert	35
13	Multifaceted Analyses of Isolated Mitochondria Establish the Anticancer Drug 2-Hydroxyoleic Acid as an Inhibitor of Substrate Oxidation and an Activator of Complex IV-Dependent State 3 Respiration 2022 ·Cells ·(unknown), Mária Péter, (unknown), (unknown), Victoria Lladó, (unknown), Ulf D. Kahlert, Dinorah Barasch, Ann Saada, Zsolt Török, Gábor Balogh, Pablo V. Escribá, Stefano Piotto, Or Kakhlon	5
14	A Novel Extracellular Matrix Gene-Based Prognostic Model to Predict Overall Survive in Patients With Glioblastoma 2022 ·Frontiers in Genetics ·Qian Chen, (unknown), (unknown), Zihao Chen, Wenjie Shi, (unknown), Ulf D. Kahlert, (unknown)	0
15	Construction of ceRNA Networks Associated With CD8 T Cells in Breast Cancer 2022 ·Frontiers in Oncology ·Zhilin Chen, (unknown), Ulf D. Kahlert, Zhitong Chen, (unknown), (unknown), Miao Chen, Rudy Leon De Wilde, Wenjie Shi	17
16	Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs) 2021 ·Cancers ·Katharina Koch, Rudolf Hartmann, Abigail K. Suwala, (unknown), Marcel A. Kamp, Michael Sabel, Hans‐Jakob Steiger, Dieter Willbold, Amit Sharma, Ulf D. Kahlert, Jarek Maciaczyk	12
17	Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic Taoism 2021 ·Redox Biology ·(unknown), Klaudia Lepka, (unknown), (unknown), Jörg Felsberg, (unknown), (unknown), Gereon Poschmann, Nan Qin, (unknown), Tim Prozorovski, Sven G. Meuth, Ulf D. Kahlert, Marc Remke, Orhan Aktaş, Guido Reifenberger, Lars Bräutigam, Benjamin Odermatt, Carsten Berndt	8
18	Association between health insurance status and malignant glioma 2020 ·Neuro-Oncology Practice ·Igor Fischer, Hendrik-Jan Mijderwijk, Ulf D. Kahlert, Marion Rapp, Michael Sabel, Daniel Hänggi, Hans‐Jakob Steiger, Marie-Thérèse Forster, Marcel A. Kamp	4
19	Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma 2020 ·Cell Death and Disease ·(unknown), Daniel Hänggi, Ulf D. Kahlert	20
20	BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model 2011 ·Clinical Cancer Research ·Eric H. Raabe, Kah Suan Lim, Julia M. Kim, Alan K. Meeker, Xinggang Mao, Guido Nikkhah, Jarek Maciaczyk, Ulf D. Kahlert, Deepali Jain, Eli E. Bar, Kenneth J. Cohen, Charles G. Eberhart	137

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact